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httpImproved characterization of popliteal aneurysms
using gadofosveset-enhanced equilibrium phase
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James Carr, MD,a Chicago, Ill
Although standard magnetic resonance angiography (MRA) has many advantages in the evaluation of peripheral artery
disease, it has poorer spatial resolution compared with computed tomographic angiography and digital subtraction
angiography. The MRA blood pool contrast agents have an extended half-life. By allowing longer imaging times, MRA
enables the acquisition of high-resolution images as well as providing simultaneous visualization of both arteries and
veins. Two cases of popliteal artery aneurysm are presented, in which MRA with a blood pool contrast agent provided
critical clues to the correct diagnosis: a traumatic pseudoaneurysm of the popliteal artery caused by a femoral osteo-
chondroma and a large fusiform popliteal aneurysm compressing the adjacent popliteal vein, causing venous congestion
and leg pain. (J Vasc Surg 2013;57:837-41.)Contrast-enhanced magnetic resonance angiography
(CE-MRA) is frequently used to assess patients with
peripheral artery disease and has some advantages
compared with computed tomography angiography
(CTA), including lack of ionizing radiation and nephro-
toxic contrast agent.1-3 Typically, MRA is performed using
a hybrid approach, combining time-resolved MRA (TR-
MRA) of the calves with ﬁrst-pass MRA (FP-MRA) of
the abdomen, pelvis, and thighs.4-6 With conventional FP
imaging, the acquisition is timed to vascular peak enhance-
ment. Conventional agents are not retained within the
intravascular space; thus, their use necessitates fast imaging
to provide the required vessel/tissue contrast, which limits
spatial resolution.7 In fact, poor spatial resolution has been
one of the drawbacks of MRA compared with CTA, which
has often been the preferred noninvasive imaging modality
for anatomic regions with small vessels.8
Gadofosveset trisodium is a gadolinium-based blood
pool contrast agent that recently was approved by the
United States Food and Drug Administration for CE-
MRA. The primary advantage of gadofosveset trisodium
is an extended intravascular half-life of up to 60 minutes.9
This extended period of enhancement allows acquisition of
images with increased spatial resolution during the equilib-
rium phase (EP) of circulation (5-10 minutes after contrast
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a combined FP and EP protocol it is possible to evaluate
both the arterial and venous systems using a single contrast
injection.
We present two cases of popliteal artery aneurysmal
disease where the addition of EP-MRA improved the
performance of standard FP-MRA in the characterization
of pathology.
CASE REPORTS
Case 1. A 17-year-old male was evaluated for acute swelling
of the medial aspect of the right thigh. Clinical examination
revealed nonpulsatile fullness in the right medial thigh. A CT of
the right lower extremity demonstrated a posteriorly directed
osteochondroma in the distal femur, adjacent to a mass that
appeared to be a venous aneurysm compressing the superﬁcial
femoral and popliteal arteries. However, because this examination
was a standard CT and not a CTA, the presence of an arterial
component to this disease could not be completely ruled out.
In order to evaluate both the arterial and the venous systems
noninvasively, CE-MRA was carried out with a 1.5-T scanner
(Magnetom Avanto; Siemens Healthcare, Erlangen, Germany)
after intravenous injection of gadofosveset trisodium. The
protocol consisted of a coronal TR-MRA of the popliteal fossae
during the contrast arterial phase, followed by EP-MRA. The
TR-MRA has been described elsewhere.4 The EP-MRA was
carried out using a free-breathing coronal three-dimensional
gradient-echo sequence (TR, 3.42 ms; TE, 1.3 ms; NEX, 2; ﬂip
angle, 20; matrix, 832  572; ﬁeld of view, 500  343 mm;
GRAPPA, 2; 0.6-mm-thick interpolated slices; voxel size,
0.6  0.6  0.6 mm3). Gadofosveset trisodium (Ablavar; Lan-
theus Medical Imaging, North Billerica, Mass) was administered
at a dose of 0.03 mmol/kg. The acquisition time of the EP
images was approximately 3 minutes.
The TR-MRA demonstrated ﬁlling of a large mass during the
arterial phase, indicating an arterial ﬁlling structure, with absence
of the popliteal artery suggesting segmental occlusion (Fig 1).837
Fig 1. A 17-year-old male with swelling of the right thigh. Sub-
tracted maximum intensity projection image of a time-resolved
magnetic resonance angiogram of the right popliteal region
demonstrates a contrast-ﬁlled mass in the popliteal fossa during the
arterial phase, suggesting a popliteal artery pseudoaneurysm. Note
that the right popliteal artery is not well depicted at the level of the
pseudoaneurysm, although it reconstitutes below the knee level.
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popliteal artery and the collection. The popliteal artery was patent
but attenuated due to compression by the vascular mass. The tip
of the osteochondroma abutted the collection. There was thrombus
within the popliteal vein, likely due to compression from the pseu-
doaneurysm. The calf arteries were patent. The ﬁndings were diag-
nostic of a right popliteal artery pseudoaneurysm caused by trauma
to the vessel from the osseous protuberance (Fig 2).
A popliteal artery pseudoaneurysm was conﬁrmed at surgery
and repaired by popliteal artery resection and end-to-end anasto-
mosis. An inferior vena cava ﬁlter was placed at the same time.
Case 2. A 51-year-old man presented with a history of swelling
of the medial left thigh. A large pulsatile mass was felt on physical
examination. A CT without contrast of the lower extremity demon-
strated a lobulated, well-circumscribed extramuscular heterogeneous
mass in the posterior distal left thigh. Iodinated contrast was not
administered due to the patient’s reduced renal function (glomerular
ﬁltration rate [GFR] <45 mL/m2/min). There was no invasion of
the adjacent soft tissue structures. Due to the lack of contrast, a ﬁnal
diagnosis could not be determined.
A targeted superﬁcial ultrasound scan of the region of concern
demonstrated a predominantly hypoechoic mass. The distal superﬁ-
cial femoral artery and the proximal popliteal artery coursed through
the lesion. The artery at the inferior aspect of the lesionwas bulbous.
No deﬁnite colorDoppler ﬂowwas identiﬁed within the hypoechoic
mass. The differential at that point included a large partially throm-
bosed aneurysm and a tumor arising from the arterial wall.
For further evaluation, MRA of the lower extremity was per-
formed. The imaging protocol and sequence parameters were the
same as in case 1. Gadofosveset trisodium, which can be used in
patients with GFR >30 mL/m2/min, was again administered at
a dose of 0.03 mmol/kg.
The TR-MRA in the arterial phase demonstrated a tortuous
popliteal arterywith a large fusiformaneurysm.Therewasno contrast
extravasation. The EP-MRA images demonstrated a well-deﬁned,
low-signal fusiform mass surrounding the aneurysm, suggesting an
aneurysm sac with mural thrombus. It did not demonstrate contrast
enhancement, ruling out an arterial wall tumor.
The aneurysm exerted extrinsic mass effect on the popliteal
vein, with resulting enlargement of the superﬁcial calf veins (Fig 3).
Because of the large amount of thrombus and artery tortu-
osity, an open aneurysm repair was chosen. The aneurysm was
repaired with a superﬁcial femoral artery to the below-the-knee
popliteal artery bypass using the great saphenous vein.DISCUSSION
TheCE-MRA uses a conventional extracellular gadolin-
ium contrast agent that extravasates rapidly into the intersti-
tial space after injection. This necessitates FP imaging during
arterial enhancement, which limits the maximum acquisi-
tion time for acquiring arterial phase images due to the
time taken for arterial bolus passage.10 This limitation in
acquisition time translates into (1) a limitation in the
maximum number of phase-encoding steps, thus decreasing
the maximum achievable spatial resolution, and (2) the
focus of CE-MRA on arterial imaging without venous
enhancement.The recent advent of gadofosveset trisodium has
permitted extended MRA acquisitions during EP, resulting
in submillimeter spatial resolution and potentially im-
proving diagnostic efﬁcacy, with concurrent depiction of
arteries and veins.
The MRA performed with gadofosveset using both FP
and EP techniques can yield sensitivity and speciﬁcity of
97% for detection of signiﬁcant disease in the lower
extremity arteries.11 In a study of 27 patients with pe-
ripheral artery disease, high-spatial-resolution EP-MRA
allowed for better agreement with digital subtraction angi-
ography (DSA) with regard to stenosis grade compared
with standard-resolution FP-MRA.10 In another study,
the diagnostic accuracy of gadofosveset-enhanced MRA
when assessing carotid artery stenoses was evaluated, with
DSA as reference.12 The authors determined the value of
FP, EP, and “combined” (FP plus EP) MRAs and found
that the diagnostic performance of CE-MRA with gadofos-
veset was similar to that of DSA in the evaluation of vessel
stenosis.12
Safety data pooled from eight studies using gadofosve-
set demonstrated an overall rate of adverse events similar to
that of placebo. For a dose of 0.03 mmol/kg, the safety
proﬁle of gadofosveset was found to be comparable with
that of other gadolinium contrast agents. To date, there
is no evidence of nephrotoxicity or nephrogenic systemic
ﬁbrosis with gadofosveset use.13
Fig 2. A 17-year-old male with swelling of the right thigh. High-resolution T1-weighted magnetic resonance
angiographic images with fat saturation, after injection of a blood pool contrast agent. a, Axial image demonstrating
a heterogeneous mass located posteromedially to the right femur, surrounding the above-the-knee right popliteal artery
(white arrow). b, Coronal image demonstrating a well-deﬁned, contrast-enhanced mass surrounded by low-signal
material (white arrow) representing thrombus. c, Axial image demonstrating a small connection between the right
popliteal artery and the enhanced mass (white arrow), characterizing a pseudoaneurysm of the popliteal artery. d, An
osteochondroma (white arrow) compresses the pseudoaneurysm and most likely is the cause of the popliteal artery
rupture. e, Axial image proximal to the mass demonstrating an enhanced popliteal artery (white arrow) and a low-signal
popliteal vein (white arrowhead) representing venous thrombosis. f, Coronal view showing that the popliteal vein is
being compressed by the pseudoaneurysm, thus explaining the origin of the venous thrombus (white arrowhead).
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tages of MRA with blood pool contrast agents by demon-
strating how EP images can improve characterization of
disease compared with use of FP images alone.In our ﬁrst case, a pseudoaneurysm of the popliteal
artery was caused by traumatic rupture of the vessel by
a femoral osteochondroma. The FP images conﬁrmed an
arterial ﬁlling structure but suggested occlusion of the
Fig 3. A51-year-oldmanwith swellingof the left thigh.a,Noncontrast computed tomography showing awell-deﬁnedmass
located posteriorly to the left femur (white arrows). b,Ultrasound scan demonstrating a soft tissuemass surrounding the left
popliteal artery in the areaof thepalpablemass.At this point, thedifferential diagnosis includes apopliteal aneurysm, apopliteal
pseudoaneurysm, and a vessel wall tumor. c, High-resolution magnetic resonance angiographic image after injection of
a blood pool contrast agent showing a patent popliteal artery, surrounded by low-signal material, typical of mural thrombus
(white arrows), characterizing a popliteal artery aneurysm. The popliteal vein is also well opaciﬁed and can be seen next to the
artery (white arrowhead). d, The aneurysm (white arrowheads) can be seen compressing the popliteal vein (white arrow).
e,Maximumintensityprojection (MIP) in thearterial phaseof the injectiondemonstrating continuitybetween the above-the-
knee popliteal artery, the dilated aneurysm, and the below-the-knee popliteal artery, further strengthening the diagnosis of
popliteal aneurysm. f, Sagittal oblique view of the MIP reformats showing an elongated, tortuous left popliteal artery.
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voxels) EP-MRA images showed the site of communica-
tion of the artery with the pseudoaneurysm, which was
not appreciated by TR-MRA. The EP-MRA images also
showed associated popliteal venous thrombus. Although
either DSA or CTA could have demonstrated some of
these ﬁndings, EP-MRA depicted all of the abnormalities
without the need for arterial puncture, ionizing radiation,
or nephrotoxic contrast media.
In the second case, iodinated contrast could not be
administered because of low GFR (<45 mL/min/1.73
m2) due to risk of contrast-induced nephropathy. Gadofos-
veset, due to its low dose and gadolinium content, can be
administered safely to patients with GFR as low as 30
mL/min/1.73m2. The noncontrast CT could not unequiv-
ocally characterize themass as an aneurysm.Ultrasound scan
demonstrated an aneurysmal popliteal artery but raised the
question of a vessel wall tumor surrounding the artery.
The EP-MRA demonstrated periluminal low signal without
contrast enhancement consistent with thrombus. The
absence of contrast enhancement showed that this structure
did not represent a tumor. The EP-MRA images also
demonstrated a compressed popliteal vein.
The potential drawbacks of using EP images with blood
pool contrast agents include motion artifacts due to the
extended scanning time and venous signal, whichmay impair
evaluation of immediately adjacent small arteries. Respiratory
motion artifact can occur due to free-breathing technique in
the abdomen and pelvis, although vascular structures are
generally not affected due to their retroperitoneal location.
A study demonstrated that EP imaging may aid in the diag-
nosis when FP image ﬁndings are inconsistent due tomotion
artifacts or inaccurate bolus timing.12 Regarding venous
signal, this dual enhancement effect was helpful in our cases
by identifying venous thrombosis that probably would have
been missed with FP-MRA.10
In summary, using the blood pool agent gadofosveset
enabled EP-MRA, employing a high spatial resolution
with simultaneous imaging of both the lower extremity
arteries and veins. Thismay improve disease characterization
as in these two cases of different types of popliteal aneurysm.
Due to the simultaneous enhancement of arteries and veins,
coincident venous disease, such as popliteal vein thrombosis,
also can be detected, which may have implications for
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